Tanuja Chitnis
Tanuja Chitnis
Professor of Neurology, Harvard Medical School
Zweryfikowany adres z rics.bwh.harvard.edu
Cytowane przez
Cytowane przez
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
DM Wingerchuk, B Banwell, JL Bennett, P Cabre, W Carroll, T Chitnis, ...
Neurology 85 (2), 177-189, 2015
Alterations of the human gut microbiome in multiple sclerosis
S Jangi, R Gandhi, LM Cox, N Li, F Von Glehn, R Yan, B Patel, ...
Nature communications 7 (1), 12015, 2016
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions …
LB Krupp, M Tardieu, MP Amato, B Banwell, T Chitnis, RC Dale, A Ghezzi, ...
Multiple Sclerosis Journal 19 (10), 1261-1267, 2013
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari, AD Salama, T Chitnis, RN Smith, H Yagita, H Akiba, ...
The Journal of experimental medicine 198 (1), 63-69, 2003
Acute disseminated encephalomyelitis
S Tenembaum, T Chitnis, J Ness, JS Hahn
Neurology 68 (16_suppl_2), S23-S36, 2007
Human polymorphism at microRNAs and microRNA target sites
MA Saunders, H Liang, WH Li
Proceedings of the National Academy of Sciences 104 (9), 3300-3305, 2007
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis
AD Salama, T Chitnis, J Imitola, MJI Ansari, H Akiba, F Tushima, M Azuma, ...
The Journal of experimental medicine 198 (1), 71-78, 2003
MRI characteristics of neuromyelitis optica spectrum disorder: an international update
HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ...
Neurology 84 (11), 1165-1173, 2015
Body size and risk of MS in two cohorts of US women
KL Munger, T Chitnis, A Ascherio
Neurology 73 (19), 1543-1550, 2009
Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis
MP Gorman, BC Healy, M Polgar-Turcsanyi, T Chitnis
Archives of neurology 66 (1), 54-59, 2009
CNS inflammation and neurodegeneration
T Chitnis, HL Weiner
The Journal of clinical investigation 127 (10), 3577-3587, 2017
Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort
DL Rotstein, BC Healy, MT Malik, T Chitnis, HL Weiner
JAMA neurology 72 (2), 152-158, 2015
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
KC O'Connor, KA McLaughlin, PL De Jager, T Chitnis, E Bettelli, C Xu, ...
Nature medicine 13 (2), 211-217, 2007
Regulatory functions of CD8+CD28 T cells in an autoimmune disease model
N Najafian, T Chitnis, AD Salama, B Zhu, C Benou, X Yuan, MR Clarkson, ...
The Journal of clinical investigation 112 (7), 1037-1048, 2003
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim, F Brilot, EP Flanagan, ...
The Lancet Neurology 22 (3), 268-282, 2023
Demographic and clinical features of neuromyelitis optica: a review
L Pandit, N Asgari, M Apiwattanakul, J Palace, F Paul, MI Leite, I Kleiter, ...
Multiple Sclerosis Journal 21 (7), 845-853, 2015
Gut microbiota in early pediatric multiple sclerosis: a case− control study
H Tremlett, DW Fadrosh, AA Faruqi, F Zhu, J Hart, S Roalstad, J Graves, ...
European journal of neurology 23 (8), 1308-1321, 2016
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ...
The Lancet Neurology 20 (9), 762-772, 2021
Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis
T Chitnis, DL Arnold, B Banwell, W Brück, A Ghezzi, G Giovannoni, ...
New England Journal of Medicine 379 (11), 1017-1027, 2018
Smoking and disease progression in multiple sclerosis
BC Healy, EN Ali, CRG Guttmann, T Chitnis, BI Glanz, G Buckle, ...
Archives of neurology 66 (7), 858-864, 2009
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20